BRK-B vs FUSB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FUSB presents a classic value trap profile: fundamentally undervalued but technically bearish. The deterministic baseline shows a stable Piotroski F-Score of 4/9 and a significant discount to both the Graham Number ($20.42) and Intrinsic Value ($29.50), with the stock trading below book value (P/B 0.84). However, this value is offset by a severely bearish technical trend (10/100), negative insider sentiment, and a historically poor earnings surprise track record. While current YoY growth is positive, the lack of momentum and micro-cap liquidity risks warrant a neutral stance.
Compare Another Pair
Related Comparisons
BRK-B vs FUSB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and First US Bancshares, Inc. (FUSB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.